Oversized Propafenone HCL Tablets Recalled Nationwide

Recall Applies to 225 mg Tablets

Watson Pharmaceuticals, Inc., is recalling 1 lot of Propafenone HCL 225 mg Tablets sold in 100 count bottles in the United States because some tablets may contain slightly higher levels of the active ingredient than specified.

The affected lot of Propafenone HCL tablets was shipped to customers between October 15, 2008 and November 26, 2008. The Lot Number is 112680A, and the expiration date is July 31, 2010. No other strengths or lots were affected.

Propafenone is a drug product used to treat cardiac arrhythmias (irregular heartbeats). It has a narrow therapeutic index, so some patients who are particularly sensitive to small variations in dose may experience potentially serious side effects, including arrhythmias (irregular heartbeat) or low blood pressure.

MARCH-24-09: Watson Announces a Nationwide Voluntary Recall of Propafenone HCL Tablets [FDA: PROPAFENONE HCL 225 MGTABLETS RECALLED]

Legal Help

If you or a loved one has suffered adverse health effects as a result of consuming this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Mar-24-09